Australians may experience poorer health outcomes unless recognition and funding of general practice research is boosted with investment in training and funding, according to the authors of a Perspective published online ...
Apr 27, 2020
0
0
My husband, Andy, has Parkinson's disease. A year ago, his neurologist recommended a new pill that he was to take at bedtime. We quickly learned that the medication would cost US$1,300 for a one-month supply of 30 pills. ...
Jan 14, 2020
0
3
Physicians who received gifts from pharmaceutical companies related to opioid medications were more likely to prescribe opioids to their patients the following year, compared to physicians who did not receive such gifts, ...
Oct 30, 2019
1
4
The U.S. Department of Veterans Affairs (VA) should expand the requirement in its disability compensation process regarding who can diagnose traumatic brain injury (TBI) to include any health care professional with pertinent ...
Apr 10, 2019
0
4
West Virginia is short on neurologists. According to David Watson, who directs the West Virginia University Headache Center, the state has just half of the neurologists it needs. This scarcity can cause problems for people ...
Mar 27, 2019
0
0
(HealthDay)—Nearly half of physicians report being burned out, but rates vary substantially by medical specialty, according to an article published in AMA Wire.
Sep 10, 2018
0
4
Despite more than two decades of advances in diagnostic criteria and technology, symptoms of Alzheimer's disease and Related Dementias (ADRD) too often go unrecognized or are misattributed, causing delays in appropriate diagnoses ...
Jul 22, 2018
0
8
(HealthDay)—Primary care physicians report that the worst administrative hassles include pre-authorization for medications and tests and managing specialty care, according to an article published in Medical Economics.
Jun 9, 2018
0
2
Due to an aging population and increasing prevalence of rheumatic disease, there are growing demands on clinicians who specialize in rheumatology. To meet these demands, the American College of Rheumatology has developed ...
Apr 19, 2018
0
5
French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.
Jan 22, 2018
0
5
